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We appreciate the comments by Ramos to our review on Chagas’ disease (CD)  in Europe [1,2]. We 
congratulate the Author and his group for the efforts made to identify people of Latin American 
(LA) origin who are infected by Trypanosoma cruzi and unaware of it using creative strategies.. 
Indeed, our intention was precisely to raise the attention of the medical community in Europe 
working out our specialty (i.e., Infectious Diseases) to the growing problem of CD in all its protean 
manifestations (Figure 1). Our wake up call was especially, but not exclusively, addressed to the 
Countries having the highest number of LA immigrants.  
We fully agree with Ramos’ last sentence when he says that CD is an “opportunity” for Physicians 
with different specializations,  but we believe the disease should be more appropriately considered a 
“call to army”.  
However, the Author’s idea to offer a serologic screening for CD to LA caregivers of elderly 
patients who are hospitalized in Medicine wards should be applauded and possibly extended to Italy 
and other countries where this phenomenon is increasingly encountered. 
Nevertheless, it is clear that individual actions that are in place also in Italy, such as those 
conducted in the last years in Milan and Bergamo [3,4] thanks to “Doctors without Borders”, are 
not sufficient per se: it is imperative that “institutional” initiatives driven by the National Health 
Care Systems are rapidly implemented.  
In this regard the Spanish model of CD screening should be adopted by the rest of the European 
countries (5). Although the efficacy of benznidazole and nifurtimox the two drugs currently 
employed in the treatment of CD is far from optimal for patients with the chronic indeterminate 
stage of the infection,  it has clearly been demonstrated that the earlier the treatment is begun, the 
better is the response. 
In addition,  up to 98% of infants with congenital CD who are treated precociously go on to acquire 
negative T. cruzi serology and parasitemia.  
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Finally it is hopeful that pharmaceutical companies may be conviced to develop novel agents s for 
the treatment of this neglected disease. 
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Figure legend: Clinical algorithm with bidirectional involvement between different specialists 
and Infectious Diseases specialist for the management of Latin American people with suspected 
or confirmed Chagas disease  
LA = Latina American: PCR= polymerase chain reaction 
 
